|Bid||56.60 x 600|
|Ask||56.62 x 700|
|Day's Range||56.24 - 57.36|
|52 Week Range||46.01 - 77.12|
|PE Ratio (TTM)||19.67|
|Dividend & Yield||1.56 (2.72%)|
|1y Target Est||N/A|
Bristol-Myers reported a net profit of ~$1.57 billion in 1Q17—compared to $1.19 billion in 1Q16. Analysts expect a net profit of $1.18 billion during 2Q16.
Bristol-Myers Squibb (BMY) reported 12% growth in its top line to ~$4.93 billion during 1Q17 due to 13% operational growth in its revenues
As of June 20, 2017, Bristol-Myers Squibb was trading at a forward PE multiple of ~18.0x—compared to the industry average of 16.0x.